Tag: Safety

Study: Weight loss achieved through metabolic surgery associated with less severe COVID-19

Editor's Note In a study published by JAMA Surgery in December 2021, the association between weight loss resulting from a metabolic surgical procedure performed pre-pandemic and less severe COVID-19 infection was analyzed in patients with obesity. Patients who underwent a procedure pre-pandemic, lost weight, and then contracted COVID-19 saw better…

Read More

By: Tarsilla Moura
March 3, 2022
Share

International Council of Nurses issues statement on Ukraine

Editor's Note The International Council of Nurses (ICN) and its more than 130 members around the world, on February 25, issued a statement saying they stand in solidarity with the people, nurses, and healthcare workers caught up in the conflict in Ukraine. In the statement, former American Nurses Association president…

Read More

By: Judy Mathias
March 2, 2022
Share

NNU president challenges latest CDC COVID-19 mask guidelines, metrics

Editor's Note OR Manager recently reported on the new Centers for Disease Control and Prevention (CDC) recommendations on when masks should be worn by the public. According to the new guidelines, the CDC now recommends the general public wear masks only in communities with a "high" level of COVID-19, which…

Read More

By: Tarsilla Moura
March 2, 2022
Share

Cybersecurity alert: Two new malware threats identified, increased risk

Editor's Note On February 23, the American Hospital Association (AHA) released a Cybersecurity Advisory report because of the heightened risk of cyberattacks due to the current Russia-Ukraine conflict. According to AHA, just this past weekend, the Cybersecurity and Infrastructure Security Agency and the FBI urged the US private sector, including…

Read More

By: Tarsilla Moura
March 1, 2022
Share

Associations update guidelines on perioperative medication use for total joint patients

Editor's Note The American College of Rheumatology and the American Association of Hip and Knee Surgeons, on February 28, released a summary of their updated guideline for the “Perioperative Management of Antirheumatic Medication in Patients with Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.” The guideline, which is…

Read More

By: Judy Mathias
March 1, 2022
Share

CDC issues new guidelines on masks

Editor's Note The Centers for Disease Control and Prevention (CDC), on February 25, issued new recommendations on when masks should be worn by the public. Under the new guidelines: In communities with “low” or “medium” levels of COVID-19, masks are not recommended for the general public, which is now more…

Read More

By: Judy Mathias
February 28, 2022
Share

FDA: Class I recall of Arrow International’s Arrow-Trerotola PTD

Editor's Note The Food and Drug Administration (FDA) on February 23 identified the recall by Arrow International (Reading, Pennsylvania), a subsidiary of Teleflex Inc, of its Arrow-Trerotola Percutaneous Thrombolytic Device (PTD) as Class I, the most serious. The recall was initiated because of the risk of tip damage during use…

Read More

By: Judy Mathias
February 24, 2022
Share

Study: COVID-19 linked with increased risk of diabetes in youths

Editor's Note According to a study in the Morbidity and Mortality Weekly Report, COVID-19 increases the risk of and may contribute to new-onset diabetes among children and adolescents, JAMA reports.  JAMA’s February 22 article notes that data from previous studies showed an average of 14% of adults hospitalized with COVID-19…

Read More

By: Tarsilla Moura
February 24, 2022
Share

Impact of COVID-19 on hospital-acquired bloodstream infections

Editor's Note This study led by researchers at Ascension Health Care, St Louis, finds that COVID-19 was associated with substantial increases in hospital-acquired bloodstream infections, which were largely attributed to COVID-19 infected patients. A total of 1,417,036 admissions in 69 US hospitals were analyzed before (703,556) and during (713,480) the…

Read More

By: Judy Mathias
February 24, 2022
Share

FDA: Class I recall of Vyaire Medical’s Bellavista Ventilators

Editor's Note The Food and Drug Administration (FDA) on February 17 identified the recall by Vyaire Medical (Mettawa, Illinois) of its Bellavista 1000 and 1000e Series Ventilators as Class I, the most serious. The recall was initiated because of issues with the software version 6.0.1600.0 or higher, after reports of…

Read More

By: Judy Mathias
February 24, 2022
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat